跳到正文
openFDA 已分级药品召回执法报告·· 26 天前精选AI 评分69

FDA 执法报告 D-0050-2027 将 Shenzhen Techdow 肝素钠注射液召回列为 II 类

FDA drug enforcement D-0050-2027: Shenzhen Techdow Pharmaceutical Co., Ltd. — Lack of Assurance of Sterility

AI 导读

FDA 执法报告 D-0050-2027 将 Shenzhen Techdow Pharmaceutical 的肝素钠注射液召回列为 II 类,原因为无菌保证不足。

推荐理由

记录列出该肝素钠注射液召回的分类级别、涉事批次与分销范围,可作为无菌保证缺陷召回档案的参照。

正文 · 原文

FDA drug recall enforcement report — D-0050-2027

Report issued: 2026-10-28. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "19 Gaoxinzhongyi Road",

"address_2": "Nanshan District",

"center_classification_date": "20261016",

"city": "Shenzhen",

"classification": "Class II",

"code_info": "Lot# CU03232A, Exp 1/31/2028",

"country": "China",

"distribution_pattern": "Nationwide in the USA.",

"event_id": "100049",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"ANDA202957"

],

"brand_name": [

"HEPARIN SODIUM"

],

"generic_name": [

"HEPARIN SODIUM"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Hepalink USA Inc."

],

"package_ndc": [

"81952-113-01",

"81952-113-06",

"81952-113-03",

"81952-113-08",

"81952-116-01",

"81952-116-06",

"81952-112-01",

"81952-112-06",

"81952-112-04",

"81952-112-09",

"81952-112-05",

"81952-112-10",

"81952-111-01",

"81952-111-06",

"81952-115-02",

"81952-115-07",

"81952-114-04",

"81952-114-09",

"81942-111-01"

],

"product_ndc": [

"81952-111",

"81952-113",

"81952-116",

"81952-112",

"81952-115",

"81952-114"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"INTRAVENOUS",

"SUBCUTANEOUS"

],

"rxcui": [

"1361226",

"1361574",

"1361615",

"1362831",

"1658647"

],

"spl_id": [

"2e8e07a4-763e-79e5-e063-6394a90a7619"

],

"spl_set_id": [

"c4c6bc1f-e0c7-fd0d-e053-2995a90abdef"

],

"substance_name": [

"HEPARIN SODIUM"

],

"unii": [

"ZZ45AB24CA"

],

"upc": [

"0381952113018",

"0381952115074",

"0381952116019",

"0381952112103",

"0381952116064",

"0381952112059",

"0381952114091",

"0381952113063",

"0381952113032",

"0381952114046",

"0381952112042",

"0381952112097",

"0381952113087",

"0381952112066",

"0381952111069"

]

},

"postal_code": "N/A",

"product_description": "Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01",

"product_quantity": "251,000 1 mL multidose vials",

"product_type": "Drugs",

"reason_for_recall": "Lack of Assurance of Sterility",

"recall_initiation_date": "20261001",

"recall_number": "D-0050-2027",

"recalling_firm": "Shenzhen Techdow Pharmaceutical Co., Ltd.",

"report_date": "20261028",

"state": "",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov